Petros Pharmaceuticals Inc Capital Reinvestment Ratio
Petros Pharmaceuticals Inc capital reinvestment ratio. Petros Pharmaceuticals Inc (PTPI) has a Capital Reinvestment Ratio of 0.01x as of December 2024, meaning it reinvests 0% of its operating cash flow ($965.40K) in capital expenditures ($5.45K). Check cash flow reinvestment rate of Petros Pharmaceuticals Inc to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Petros Pharmaceuticals Inc (2018–2019)
Capital reinvestment ratio of Petros Pharmaceuticals Inc from 2018 to 2019. This chart tracks Petros Pharmaceuticals Inc's Capital Reinvestment Ratio across 2 annual periods. Also explore how fast is Petros Pharmaceuticals Inc growing its equity to track the company's year-over-year net asset growth rate.
Petros Pharmaceuticals Inc Capital Reinvestment Ratio by Year (2018–2019)
Petros Pharmaceuticals Inc capital reinvestment ratio by year from 2018 to 2019. For the full cash flow conversion analysis, see PTPI cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.03x | $2.53 Million | $71.54K | ▼ -87.9% |
| 2018 | 0.23x | $8.02 Million | $1.88 Million | — |